DrugPatentWatch Database Preview
Ajanta Pharma Ltd Company Profile
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has thirty-three approved drugs.
There is one tentative approval on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 26 |
| NDAs: | 33 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Ajanta Pharma Ltd: | See patent lawsuits for Ajanta Pharma Ltd |
Drugs and US Patents for Ajanta Pharma Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 209859-002 | Sep 27, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ajanta Pharma Ltd | FENOFIBRATE | fenofibrate | TABLET;ORAL | 210138-001 | Jul 23, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ajanta Pharma Ltd | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 206174-002 | Sep 12, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
